PEPentwater Capital Management LP
Institutional investor · Portfolio as of Q4 2023
Top Holdings109 positions
PIONEER NAT RES CO | 5.8M | $1.3B | 14.7% | — | — | 1 qtr | New 98 |
State Street Spdr S&p 500 Etf Trust TR UNIT | 2.1M | $990.9M | 11.1% | — | — | — | Increased — |
SPLUNK INC | 4.1M | $618.5M | 6.9% | — | — | 2 qtrssince 2023-Q3 | Increased 88 |
HESS CORP | 3.9M | $560.1M | 6.3% | — | — | 1 qtr | New 97 |
UNITED STATES STEEL CORP | 10.4M | $506.9M | 5.7% | — | — | 2 qtrssince 2023-Q3 | Increased 98 |
HESS CORP | 3.2M | $455.8M | 5.1% | — | — | — | New — |
KARUNA THERAPEUTICS INC | 1.1M | $337.5M | 3.8% | — | — | 19 qtrssince 2019-Q2 | Increased 92 |
SPLUNK INC | 2.2M | $337.2M | 3.8% | — | — | — | Increased — |
UNITED STATES STEEL CORP | 6.5M | $318.1M | 3.6% | — | — | — | Increased — |
Chevron Corp. | 1.4M | $213.3M | 2.4% | — | — | — | New — |
CAPRI HOLDINGS LIMITED | 4M | $201M | 2.3% | $50.84 | -1.19% | 2 qtrssince 2023-Q3 | Increased 85 |
CAPRI HOLDINGS LIMITED | 3.6M | $178.4M | 2.0% | — | — | — | Increased — |
IMMUNOGEN INC | 5.7M | $167.9M | 1.9% | — | — | 1 qtr | New 69 |
BOEING CO | 617,500 | $161M | 1.8% | $198.51 | +31.31% | 11 qtrssince 2021-Q2 | Decreased 0 |
EXXON MOBIL CORP | 1.1M | $105M | 1.2% | — | — | — | New — |
KENVUE INC COM | 4.9M | $104.6M | 1.2% | — | — | — | Increased — |
WESTROCK CO | 2.5M | $101.9M | 1.1% | — | — | 2 qtrssince 2023-Q3 | Increased 63 |
BOEING CO | 388,000 | $101.1M | 1.1% | — | — | — | Decreased — |
ENDEAVOR GROUP HLDGS INC | 4.3M | $101.1M | 1.1% | — | — | — | New — |
ENDEAVOR GROUP HLDGS INC | 4.2M | $100.1M | 1.1% | — | — | 1 qtr | New 68 |
Pentwater Capital Management LP manages $8.9B across 109 positions as of Q4 2023. Top holdings: PXD (14.7%), SPY puts (11.1%), SPLK (6.9%). Fund DNA: Momentum Trader. HoldingsIntel Score: 2/5.0.
Active quarter - 24 new positions, 25 exits, 18 increased. Top move: PXD (NEW, conviction 98). Portfolio: $8.9B across 109 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR